InvestorsHub Logo

DewDiligence

06/27/07 2:47 PM

#1673 RE: genisi #1672

>The 12 years of market exclusivity is not exactly good news<

I don’t think the exclusivity period will be 12 years in the final bill. Bear in mind that Sen. Kennedy represents Massachusetts, the home of several influential Big Bio players (e.g. BIIB, GENZ) and no major generic-drug companies.